Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Vaccines|June 24, 2022
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis PatientsHelly Hammer, Robert Hoepner, Christoph Friedli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 16, 2020
Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective studyLara Diem, Ariadne Daponte, Oliver Findling, et al.
European Journal of Neurology|November 28, 2022
Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literatureAnina Schwarzwald, Anke Salmen, Alejandro Xavier León Betancourt, et al.
Therapeutic Advances in Neurological Disorders|March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse eventsPauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
European Journal of Neurology|February 23, 2023
Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literatureAlejandro León Betancourt, Anina Schwarzwald, Alban Millonig, et al.
CNS Neuroscience & Therapeutics|August 17, 2022
Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey studyLara Diem, Anina Schwarzwald, Christoph Friedli, et al.
CNS Neuroscience & Therapeutics|November 10, 2018
Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional studyAndrei Miclea, Anke Salmen, Greta Zoehner, et al.
Journal of Central Nervous System Disease|May 31, 2022
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19Lara Diem, Livia Fregolente-Gomes, Jan D Warncke, et al.
Therapeutic Advances in Neurological Disorders|October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease courseGreta Zoehner, Andrei Miclea, Anke Salmen, et al.
CNS Neuroscience & Therapeutics|October 13, 2020
Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohortKrenar Veselaj, Nicole Kamber, Myriam Briner, et al.
Pageof 3